Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis  

作　　者：ángel Edo Juan Francisco Espinosa-Parrilla 

机构地区：[1]Gene Therapy for Central Nervous System Group,Vall d'Hebron [2]Institut de Recerca,Hospital Universitari Vall d'Hebron,Barcelona,Spain

出　　处：《Neural Regeneration Research》2017年第10期1605-1606,共2页中国神经再生研究（英文版）

摘　　要：Gene therapy as strategy against autoimmune diseases： In the last century, human societies have witnessed remarkable improvements in wellness and life expectancy, thanks to the consolidation of mod- ern science and medicine. But, while some infectious and other dis- eases, have been almost fully controlled, pathologies associated with intrinsic factors and longevity have increased in incidence.Gene therapy as strategy against autoimmune diseases： In the last century, human societies have witnessed remarkable improvements in wellness and life expectancy, thanks to the consolidation of mod- ern science and medicine. But, while some infectious and other dis- eases, have been almost fully controlled, pathologies associated with intrinsic factors and longevity have increased in incidence.

分 类 号：R744.51[医药卫生—神经病学与精神病学]